(C) RLX-treated normoglycaemic (db+/+m) wounds
(C) RLX-treated normoglycaemic (db+/+m) wounds. RLX improved the impaired wound healing, improved the staining of MMP-11 (matrix metalloproteinase-11) and elevated wound-breaking power at time 12 in diabetic mice. Immunohistochemistry showed that RLX in diabetic pets augmented new vessel development by stimulating both vasculogenesis and angiogenesis. RLX significantly decreased enough time to comprehensive skin normalization which…
